Johns Hopkins University Psilocybin & Cancer

In this study, 44 cancer patients will receive psilocybin treatment in two sessions over a 2-month period followed by a 6-month follow-up. Participants will receive thorough preparation with two trained facilitators before the first psilocybin session. This study specifically focuses on spiritual and insightful experiences facilitated by psilocybin as a healing factor in patients who are psychologically distressed about their cancer diagnosis. Patients with and without disease progression are eligible. For more information on criteria for participation please visit www.cancer-insight.org.

Outcome measures include measures of psychological well-being, mystical/spiritual experience, quality of life, anxiety, depressed mood, attitudes about death, and blood markers of stress and immune function. To learn more about the study, please visit: www.cancer-insight.org.

To hear what past subjects have said about the study, please see the films at the left featuring Janeen and Clark, who both participated in the Johns Hopkins University trial.

The study is actively recruiting, and potential subjects can be referred to the study coordinator, Mary Cosimano at (410) 550-5990, or by email to: Roland Griffiths.